Examples of etiological markers include overexpressed or mutant ERBB2/HER2 (20) in breast cancer, mutant EGFR in lung cancer (21), and mutant NRAS or BRAF in melanoma (22). This evidence concerns the gene ERBB2 and lung carcinoma.